Devki Sukhtankar, Ph.D.
Affiliations: | 2011 | Cancer Biology | University of Arizona, Tucson, AZ |
Area:
pain, opioids, pharmacologyGoogle:
"Devki Sukhtankar"Mean distance: 18.84 (cluster 32)
Parents
Sign in to add mentor| Frank Porreca | grad student | 2011 | University of Arizona | |
| (Mechanisms underlying cancer-induced bone pain.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Havelin J, Imbert I, Sukhtankar D, et al. (2017) Mediation of movement-induced breakthrough cancer pain by IB4 binding nociceptors in rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience |
| Remeniuk B, Sukhtankar D, Okun A, et al. (2015) Behavioral and Neurochemical Analysis of Ongoing Bone Cancer Pain in Rats. Pain |
| Ding H, Hayashida K, Suto T, et al. (2015) Supraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non-human primates. British Journal of Pharmacology. 172: 3302-12 |
| Sukhtankar DD, Lee H, Rice KC, et al. (2014) Differential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain Psychopharmacology. 231: 1377-1387 |
| Sukhtankar DD, Zaveri NT, Husbands SM, et al. (2013) Effects of spinally administered bifunctional nociceptin/orphanin FQ peptide receptor/μ-opioid receptor ligands in mouse models of neuropathic and inflammatory pain. The Journal of Pharmacology and Experimental Therapeutics. 346: 11-22 |
| Sukhtankar D, Ko MC. (2013) Pharmacological investigation of NOP-related ligands as analgesics without abuse liability Acs Symposium Series. 1131: 393-416 |
| Sukhtankar D, Okun A, Chandramouli A, et al. (2011) Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain. Molecular Pain. 7: 81 |
| Ondoua A, Hanlon K, Largent-Milnes T, et al. (2011) CB2 receptor agonists act as a disease-modifying treatment by attenuating breast cancer-induced bone pain and improving bone health in a murine model of breast cancer metastases The Journal of Pain. 12: P51 |